Skip to main content

Table 1 Population characteristics

From: No association between early antiretroviral therapy during pregnancy and plasma levels of angiogenic factors: a cohort study

Characteristics

1st trimester n = 159

2nd trimester n = 159

Total n = 159

No ART n = 50

PI

n = 89

Other regimens

n = 20

No ART

n = 6

PI

n = 131

Other regimens

n = 22

 

Maternal age at delivery, years, mean ± SD

31.7 ± 5.3

33.1 ± 4.9

31.3 ± 5.0

29.7 ± 3.0

32.5 ± 5.1

32.3 ± 5.4

32.4 ± 5.1

Ethnicity, n (%)

 Afro-Caribbean

43 (86.0)

69 (77.5)

18 (90.0)

6 (100.0)

103 (78.6)

21 (95.5)

130 (81.8)

 Caucasian

7 (14.0)

17 (19.1)

1 (5.0)

0 (0.0)

24 (18.3)

1 (4.5)

25 (15.7)

 Other

0 (0.0)

3 (3.4)

1 (5.0)

0 (0.0)

0 (0.0)

0 (0.0)

4 (2.5)

BMI, kg/m2, median [IQR]

27.2 [24.9–31.0]

25.8 [22.8–29.9]

26.5 [22.9–30.3]

28.2 [24.4–34.9]

26.4 [23.6–30.4]

24.9 [23.2–28.7]

26.3 [23.5–30.2]

Parity, n (%)

 0

15 (30.0)

31 (34.8)

6 (30.0)

2 (33.3)

41 (31.3)

9 (40.9)

52 (32.7)

 1

18 (36.0)

31 (34.8)

10 (50.0)

4 (66.7)

45 (34.4)

10 (45.5)

59 (37.1)

 2

12 (24.0)

14 (15.7)

1 (5.0)

0 (0.0)

26 (19.8)

1 (4.5)

27 (17.0)

 3 and more

5 (10)

13 (14.7)

3 (15.0)

0 (0.0)

19 (14.5)

2 (9.1)

21 (13.2)

Smoker, n (%)

6 (12.0)

8 (9.0)

1 (5.0)

0 (0.0)

6 (4.6)

0 (0.0)

 

Chronic hypertension, n (%)

2 (4.0)

1 (1.1)

0 (0.0)

0 (0.0)

3 (2.3)

0 (0.0)

3 (1.9)

Gestational hypertension or preeclampsia, n (%)

4 (8.0)

9 (10.1)

2 (10.0)

1 (16.7)

11 (7.2)

3 (13.6)

15 (9.4)

Sex of fetus, n (%)

 Male

25 (50.0)

53 (59.6)

4 (20.0)

1 (16.7)

76 (58.0)

5 (22.7)

82 (51.6)

CD4 counta, median [IQR]

 Total/mm3

495.5 [270.0–679.5]

573.5 [404.25–751.5]

580.5 [372.5–733.5]

493.5 [193.5–859.5]

561.0 [378.5–722.5]

645.0 [470.75–1056.0]

 

 Percentage

25.0 [16.0–33.0]

32.0 [25.0–38.5]

33.5 [23.0–43.5]

26.0 [17.0–37.0]

31.0 [24.0–39.0]

40.0 [27.0–44.0]

 

Undetectable viral loada, n (%)

4 (8.0)

72 (80.9)

16 (80.0)

2 (33.3)

94 (71.8)

19 (86.4)

 

Pregnancy outcome, n (%)

 SGA

8 (16.0)

19 (21.3)

2 (10.0)

1 (16.7)

26 (19.8)

2 (9.1)

29 (18.6)

 Preterm birth

6 (12.0)

17 (19.1)

2 (10.0)

0 (0.0)

22 (16.8)

3 (13.6)

25 (15.7)

Gestationnal agea

weeks, median [IQR]

9.7 [7.9–11.9]

10.7 [8.9–11.9]

10.7 [7.9–11.8]

18.3 [15.8–19.1]

19.6 [17.1–21.3]

19.3 [17.1–23.0]

 
  1. SD Standard deviation, BMI Body mass index, IQR Interquartile range, ART Antiretroviral therapy, SGA Small for gestational age
  2. aAt sampling